These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7434856)

  • 1. [Lidocain clearance after oral and intravenous application in rats with low grade ANIT-cholestasis and galactosamine-induced hepatitis (author's transl)].
    Fuchshofen M; Heusler H; Lutz B; Mora E; Richter E
    Z Gastroenterol; 1980 Aug; 18(8):436-42. PubMed ID: 7434856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravenous and oral galactose loading of rats suffering from galactosamine hepatitis and ANIT-cholestasis; comparison of the kinetics in vivo and the galactose metabolism in the liver in vitro (author's transl)].
    Richter E; Hofstetter GJ; Seifert H
    Z Gastroenterol; 1979 Oct; 17(10):713-21. PubMed ID: 524947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations of the total flavonoids extracted from flowers of Abelmoschus manihot (L.) Medic against α-naphthylisothiocyanate-induced cholestatic liver injury in rats.
    Yan JY; Ai G; Zhang XJ; Xu HJ; Huang ZM
    J Ethnopharmacol; 2015 Aug; 172():202-13. PubMed ID: 26133062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of melatonin against alpha-naphthylisothiocyanate-induced liver injury in rats.
    Ohta Y; Kongo M; Sasaki E; Ishiguro I; Harada N
    J Pineal Res; 2000 Aug; 29(1):15-23. PubMed ID: 10949536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal relationship of changes in hepatobiliary function and morphology in rats following alpha-naphthylisothiocyanate (ANIT) administration.
    Kossor DC; Meunier PC; Handler JA; Sozio RS; Goldstein RS
    Toxicol Appl Pharmacol; 1993 Mar; 119(1):108-14. PubMed ID: 8470113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Galactosamine-hepatitis and anit-cholestasis. Liver damage caused by D-galactosamine-hydrochloride and 1-naphthyl-isothiocyanate (anit)].
    Leinweber B
    Fortschr Med; 1973 Jun; 91(18):792-6. PubMed ID: 4723864
    [No Abstract]   [Full Text] [Related]  

  • 7. Age-dependent phagocytosis of erythrocytes by the isolated perfused rat liver after galactosamine hepatitis and alpha-naphthylisothiocyanate cholestasis.
    Vömel T; Platt D
    Arch Gerontol Geriatr; 1986 Dec; 5(4):351-9. PubMed ID: 3827405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Drug metabolism in patients with liver disease (author's transl)].
    Richter E; Epping J; Fuchshofen-Röckel M; Heusler H; Zilly W
    Leber Magen Darm; 1980 Oct; 10(5):234-40. PubMed ID: 7464410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hexobarbital-oxidation in vivo and in vitro in rats with bile duct ligation or ANIT-cholestasis (author's transl)].
    Brachtel D; Gallenkamp H; Richter E
    Z Gastroenterol; 1977 Jun; 15(6):378-80. PubMed ID: 888487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between blood clearance and hepatic uptake of 99mTc-phytate in rats with hepatic injury.
    Shibata H; Hisano T; Kohno M
    Radioisotopes; 1989 Oct; 38(10):426-9. PubMed ID: 2813859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental and clinical studies on enzymes of mitochondria in various liver diseases; with special reference to alcoholic liver disease (author's transl)].
    Ohtani N
    Hokkaido Igaku Zasshi; 1980 Jan; 55(1):67-80. PubMed ID: 6250959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative transport pathways of cholephilic 14C-hexobarbital metabolites in rats with experimental hepatitis and cholestasis.
    Richter E; Joeres R; Buschmann J; Zilly W
    Acta Hepatogastroenterol (Stuttg); 1979 Dec; 26(6):429-34. PubMed ID: 549423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biliary excretion of taurocholate, organic anions and vinblastine in rats with alpha-naphthylisothiocyanate-induced cholestasis.
    Kurihara H; Sano N; Takikawa H
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1069-74. PubMed ID: 15955216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Symposion B: Experimental cholestasis--in vitro metabolism and in vivo metabolic clearance of hexobarbital in rats with ANIT-cholestasis].
    Richter E; Brachtel D; Gallenkamp H; Zilly W
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():269-71. PubMed ID: 829378
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the protective effect of Zhi-Zi-da-Huang decoction on acute liver injury with cholestasis induced by α-naphthylisothiocyanate in rats.
    Chen KL; Bi KS; Han F; Zhu HY; Zhang XS; Mao XJ; Yin R
    J Ethnopharmacol; 2015 Aug; 172():402-9. PubMed ID: 26163196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-Tocopherol protects against alpha-naphthylisothiocyanate-induced hepatotoxicity in rats less effectively than melatonin.
    Ohta Y; Kongo-Nishimura M; Imai Y; Matsura T; Kitagawa A; Yamada K
    Chem Biol Interact; 2006 Jun; 161(2):115-24. PubMed ID: 16626673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of route of administration and blood flow on hepatic drug elimination.
    Shand DG; Kornhauser DM; Wilkinson GR
    J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phospholipids in endoplasmic reticulum - their relationship to drug metabolism in experimental liver disease.
    Gallenkamp H
    Acta Hepatogastroenterol (Stuttg); 1977 Oct; 24(5):309-16. PubMed ID: 930533
    [No Abstract]   [Full Text] [Related]  

  • 19. Bile duct obstruction is not a prerequisite for type I biliary epithelial cell hyperplasia.
    Kossor DC; Meunier PC; Dulik DM; Leonard TB; Goldstein RS
    Toxicol Appl Pharmacol; 1998 Oct; 152(2):327-38. PubMed ID: 9853002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of betaine supplementation on changes in hepatic metabolism of sulfur-containing amino acids and experimental cholestasis induced by alpha-naphthylisothiocyanate.
    Kim YC; Jung YS; Kim SK
    Food Chem Toxicol; 2005 May; 43(5):663-70. PubMed ID: 15778005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.